Pharma Lobby Captures UN Biodiversity Fund to Privatize Genetic Wealth, Undermine Global South Sovereignty
Original framing: “How Big Pharma Tried to Weaken the Rules of the UN’s Nature Fund” — DeSmog
Indigenous peoples have long governed genetic resources through customary laws requiring reciprocal exchange, not extraction — the Quechua principle of 'ayni' (reciprocity) and the Dene concept of 'respect for all relations' directly contradict the IFPMA's push for voluntary, non-binding contributions. The UN fund's original design incorporated Article 8(j) of the CBD and the Nagoya Protocol's requirement for prior informed consent from Indigenous communities, provisions IFPMA sought to weaken by redefining 'utilization of genetic resources' to exclude digital sequence information. This erasure continues a 500-year pattern where Indigenous knowledge is treated as raw material rather than sovereign intellectual property.
The IFPMA's lobbying at COP17 is not an isolated incident but the latest maneuver in a 500-year colonial project to convert the genetic wealth of the Global South into Northern private property — a project now accelerated by digital sequence information that bypasses physical access rules.
The UN's Global Biodiversity Framework Fund, designed to close a $700 billion annual conservation finance gap, is being hollowed out before it operates, with Indigenous sovereignty over traditional knowledge treated as a regulatory nuisance rather than the legal and ethical foundation of the Convention on Biological Diversity. Restoring the fund's integrity requires centering the Māori Te Mana Raraunga model of data sovereignty, the African Group's demand for mandatory contributions, and the Andean principle of reciprocal exchange — not as cultural add-ons but as the governance architecture without which the fund becomes another instrument of extraction. The trickster's lesson is clear: when the god of commerce writes the rules of the commons, the commons disappears.